In the bustling digital amphitheater of Tribe Public’s latest CEO Presentation, the question of the hour was as sharp as it was timely: “Is the beaten down biotech sector the smartest bet in today’s volatile market?” With a flourish of slides and…
Once upon a time in east London, a boy with a mop of hair and a penchant for bending footballs around hapless defenders dreamed of wearing the red of Manchester United and the white of England. That boy, David Beckham, would one…
A Comeback Worth Cheering
After a long stretch that could best be described as a financial siesta, the U.S. IPO market is finally stretching its legs and putting on a show. As of June 11, 2025, U.S. IPOs have raised a…
Rio Tinto (RIO), the mining titan with a knack for innovation, has set its sights on London Tech Week 2025—and it’s not just there for the canapés. As the only mining company gracing this major technology event, Rio Tinto is making waves…
The biotech sector, long known for its rollercoaster fortunes, is currently experiencing a particularly stomach-churning drop. If the industry were an amusement park, the “Trump Policy Plunge” would be its latest and most daunting attraction—one that’s left investors clutching their wallets a…
A Fresh Face on Wall Street On a lively Friday, June 6, Omada Health (OMDA) stepped onto the Nasdaq stage, becoming the second major digital health company to go public in 2025—a year that’s already shaping up as a comeback for healthcare…
In a move that could electrify the future of clean energy, C5 Capital—a global investment firm with a flair for innovation—has inked a Memorandum of Understanding with Sibanye-Stillwater (SBSW), the South African mining heavyweight, to jointly pursue advanced nuclear energy ventures across…
In a move that has set the fast-casual dining world abuzz, Roark Capital—the Atlanta-based private equity titan already holding the reins of Subway, Dunkin’, and Arby’s—has added another sizzling brand to its ever-expanding menu: Dave’s Hot Chicken. The deal, valued at a…
In the ever-evolving world of neuroscience drug development, on May 22, Serina Therapeutics (NYSE American: SER) announced that they have added a formidable new player to its Board of Directors: Dr. Stephen Brannan, a name that resonates with both gravitas and…
GeoVax Labs, Inc. (NASDAQ: GOVX) is taking a well-deserved victory lap as the U.S. Senate moves forward with bipartisan legislation to bolster America’s domestic vaccine manufacturing muscle—a development that aligns perfectly with GeoVax’s own ambitions and expertise6 . Let’s…